Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Rockwell Medical (RMTI) over the last 17 years, with Q3 2025 value amounting to $244000.0.

  • Rockwell Medical's Change in Receivables rose 11243.0% to $244000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$549000.0, marking a year-over-year decrease of 1342.98%. This contributed to the annual value of -$2.6 million for FY2024, which is 15622.58% down from last year.
  • As of Q3 2025, Rockwell Medical's Change in Receivables stood at $244000.0, which was up 11243.0% from -$1.6 million recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's Change in Receivables ranged from a high of $4.0 million in Q3 2023 and a low of -$2.0 million during Q3 2024
  • Moreover, its 5-year median value for Change in Receivables was -$123000.0 (2021), whereas its average is $218789.5.
  • Its Change in Receivables has fluctuated over the past 5 years, first plummeted by 80081.3% in 2022, then surged by 64633.47% in 2023.
  • Rockwell Medical's Change in Receivables (Quarter) stood at -$123000.0 in 2021, then plummeted by 800.81% to -$1.1 million in 2022, then surged by 238.99% to $1.5 million in 2023, then plummeted by 138.05% to -$586000.0 in 2024, then surged by 141.64% to $244000.0 in 2025.
  • Its last three reported values are $244000.0 in Q3 2025, -$1.6 million for Q2 2025, and $1.4 million during Q1 2025.